These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32246324)

  • 41. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
    Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.
    Chaukiyal P; Nautiyal A; Radhakrishnan S; Singh S; Navaneethan SD
    Thromb Haemost; 2008 Jan; 99(1):38-43. PubMed ID: 18217132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis.
    Chen H; Tao R; Zhao H; Jiang J; Yang J
    Medicine (Baltimore); 2020 Jan; 99(5):e19000. PubMed ID: 32000440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjunctive Intermittent Pneumatic Compression in Hospitalized Patients Receiving Pharmacologic Prophylaxis for Venous Thromboprophylaxis: A Systematic Review and Meta-Analysis.
    Fan C; Jia L; Fang F; Zhang Y; Faramand A; Chong W; Hai Y
    J Nurs Scholarsh; 2020 Jul; 52(4):397-405. PubMed ID: 32468697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial.
    Kimpton M; Wells PS; Carrier M
    Thromb Res; 2018 Apr; 164 Suppl 1():S124-S129. PubMed ID: 29703470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.
    Loke YK; Kwok CS
    J Clin Pharm Ther; 2011 Feb; 36(1):111-24. PubMed ID: 21198726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anticoagulation for people with cancer and central venous catheters.
    Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WITHDRAWN: Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction).
    Alikhan R; Cohen AT
    Cochrane Database Syst Rev; 2010 Feb; (2):CD003747. PubMed ID: 20166070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
    Thaler J; Ay C; Pabinger I
    Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis.
    Jacobson B; Rambiritch V; Paek D; Sayre T; Naidoo P; Shan J; Leisegang R
    Adv Ther; 2020 Jan; 37(1):27-40. PubMed ID: 31673991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct oral anticoagulants for extended-duration thromboprophylaxis in hospitalized medically ill patients: are we there yet?
    Al Yami MS; Alfayez OM; Kurdi SM; Alsheikh R
    J Thromb Thrombolysis; 2017 Jul; 44(1):1-8. PubMed ID: 28197755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis.
    Akl EA; Kamath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook DJ; Schünemann HJ
    Cancer; 2008 Jun; 112(11):2483-92. PubMed ID: 18404702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Barba M; Rohilla S; Terrenato I; Sperati F; Muti P; Schünemann HJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006650. PubMed ID: 18425959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness and Tolerability of Anticoagulants for Thromboprophylaxis after Major Joint Surgery: a Network Meta-Analysis.
    Wang Z; Zheng J; Zhao Y; Xiang Y; Chen X; Jin Y
    Cell Physiol Biochem; 2017; 42(5):1999-2020. PubMed ID: 28793291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
    Khorana AA; Francis CW; Kuderer NM; Carrier M; Ortel TL; Wun T; Rubens D; Hobbs S; Iyer R; Peterson D; Baran A; Kaproth-Joslin K; Lyman GH
    Thromb Res; 2017 Mar; 151():89-95. PubMed ID: 28139259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy and safety of low-molecular-weight heparin use for cancer treatment: a meta-analysis.
    Che DH; Cao JY; Shang LH; Man YC; Yu Y
    Eur J Intern Med; 2013 Jul; 24(5):433-9. PubMed ID: 23385011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006649. PubMed ID: 21678360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006649. PubMed ID: 21491395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006649. PubMed ID: 21328285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Labedi N; Terrenato I; Barba M; Sperati F; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2011 Nov; (11):CD009447. PubMed ID: 22071865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.